Clonal Expansion of Infected CD4+ T Cells in People Living with HIV
Open Access
Abstract
HIV infection is not curable with current antiretroviral therapy (ART) because a small fraction of CD4+ T cells infected prior to ART initiation persists. Understanding the nature of this latent reservoir and how it is created is essential to development of potentially curative strategies. The discovery that a large fraction of the persistently infected cells in individuals on suppressive ART are members of large clones greatly changed our view of the reservoir and how it arises. Rather than being the products of infection of resting cells, as was once thought, HIV persistence is largely or entirely a consequence of infection of cells that are either expanding or are destined to expand, primarily due to antigen-driven activation. Although most of the clones carry defective proviruses, some carry intact infectious proviruses; these clones comprise the majority of the reservoir. A large majority of both the defective and the intact infectious proviruses in clones of infected cells are transcriptionally silent; however, a small fraction expresses a few copies of unspliced HIV RNA. A much smaller fraction is responsible for production of low levels of infectious virus, which can rekindle infection when ART is stopped. Further understanding of the reservoir will be needed to clarify the mechanism(s) by which provirus expression is controlled in the clones of cells that constitute the reservoir.Keywords
This publication has 88 references indexed in Scilit:
- HIV latency and integration site placement in five cell-based modelsRetrovirology, 2013
- Estimating abundances of retroviral insertion sites from DNA fragment length dataBioinformatics, 2012
- HIV-1 Continues To Replicate and Evolve in Patients with Natural Control of HIV InfectionJournal of Virology, 2010
- The mechanism of retroviral integration from X-ray structures of its key intermediatesNature, 2010
- Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapyProceedings of the National Academy of Sciences, 2009
- Integration of HIV-1 caused STAT3-associated B cell lymphoma in an AIDS patientMicrobes and Infection, 2007
- Residual Human Immunodeficiency Virus Type 1 Viremia in Some Patients on Antiretroviral Therapy Is Dominated by a Small Number of Invariant Clones Rarely Found in Circulating CD4 + T CellsJournal of Virology, 2006
- Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site PreferencesPLOS Biology, 2004
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Viral dynamics in human immunodeficiency virus type 1 infectionNature, 1995